loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2014_061___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Samyang Biopharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SAMYANG BIOPHARMACEUTICALS CORPORATION Daejeon KR (1)

    filter

    01 Paclitaxel, Produced by a semi-synthetic process (1)

    filter

    01 South Korea (1)

    filter

    01 Expired (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    SAMYANG BIOPHARMACEUTICALS CORPORAT...

    Contact Supplier
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Paclitaxel, Produced by a semi-synthetic process

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2014-061 - Rev 00
    Expired
    Chemical
    2016-01-14
    2021-01-14
    1794
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2014-061 - Rev 00 of Samyang Biopharmaceuticals Corporation Daejeon Kr

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2014-061 - Rev 00 of Samyang Biopharmaceuticals Corporation Daejeon Kr 1

    20

    Samyang Biopharmaceuticals Corporation Daejeon Kr, based in South Korea, is a pharmaceutical company that stands out with its certifications from EDQM.

    One of their significant offerings is Paclitaxel, Produced by a semi-synthetic process, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2014-061 - Rev 00

    This Chemical Type CEP, issued on January 14, 2016, remains in force until January 14, 2021, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1794 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY